PK, safety and acceptability data and practical guidance on the optimal dosing of new more child-friendly formulations of...
This study will compare the efficacy and safety of 26 weeks of delamanid (DLM) versus 26 weeks of isoniazid (INH) for preventing...
A major disadvantage of giving SD NVP is the potential for maternal development of NVP resistance and additional resistance to...
A5329 is a study for people who are infected with both HIV and the Hepatitis C virus (HCV) and have never taken Hepatitis C...
A5327 SWIFT-C is a Phase I, open-label, two-cohort clinical trial, in which between 44 and 50 acutely HCV-infected HIV-1...
